Neuren Pharmaceuticals Limited

OTC
NURPF
Stock
Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Neuren Pharmaceuticals Limited

16.0016.0014.0014.0012.0012.0010.0010.008.008.006.006.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
9/10
11.26 54.24 -79.23% 1053.31 -98.93%
P/S 7.38 4.62 59.69%
P/BV 4.4 4.2 4.76%
P/FCF 0 16.2 -100%
Ev/Ebitda 8.91 14.71 -39.4%
Ev/S 7.36 4.05 81.76%
Ev/FCF -141.56 20.97 -774.93%
E/P 0 1.63 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
10/10
82.64 25.2 227.93% -23.46 -452.25%
ROE 49.92 12.46 300.49%
ROA 43.2 6.23 593.17%
ROIC 0 15.34 -100%
ROS 65.51 12.71 415.45%
ROCE 49.23 14.68 235.32%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0 6.22 -100% 0 0%
Nеt Debt/Ebitda -0.0176 -3.47 -99.49%
Debt/Ratio 0 0.2246 -100%
Debt/Equity 0.1259 1 -87.43%
Debt/Net Income 0 18.36 -100%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 2.28 -100% 0 0%
Number of years of dividend growth 0 1.59 -100%
DSI 0 0.7935 -100%
Average dividend growth 0 -303.64 -100%
Average percentage for 5 years 0 2.59 -100%
Average percentage for payments 0 167.32 -100%
Difference from average difference in sector -2.28

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
30141.56 -98.5 -30700.57%
Growth impulse Ebitda in 5 years -1980.99 -98.62 1908.71%
Growth impulse Net Income in 5 years -1645.12 -98.32 1573.23%
Growth impulse FCF in 5 years 39.53 -98.32 -140.21%
Growth impulse EPS in 5 years -1612.71 -82.03 1866%
IP Score
5.34/10

Similar companies

Chugai Pharmaceutical Co., Ltd.

Astellas Pharma Inc.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription